My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
OBC slumps after reverse turnaround in Q4
May 12,2017

The result was announced during trading hours today, 12 May 2017.

Meanwhile, the BSE Sensex was down 62.83 points, or 0.21%, to 30,188.15. The S&P BSE Mid-Cap index was down 102.68 points, or 0.69%, to 14,854.45.

On BSE, so far 15.16 lakh shares were traded in the counter, compared with an average volume of 3.94 lakh shares in the past one quarter. The stock hit a high of Rs 177.60 and a low of Rs 161.15 so far during the day. The stock hit a 52-week high of Rs 190.80 on 5 May 2017. The stock hit a 52-week low of Rs 76.80 on 24 May 2016.

The stock had outperformed the market over the past one month till 11 May 2017, rising 15.29% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, surging 39.33% as against Sensexs 6.76% rise.

The mid-cap state-run bank has an equity capital of Rs 346.17 crore. Face value per share is Rs 10.

Oriental Bank of Commerce (OBCs) total income 7.19% to Rs 5093.84 crore in Q4 March 2017 over Q4 March 2016.

The banks gross non-performing assets (NPAs) stood at Rs 22859.27 crore as on 31 March 2017 as against Rs 20492.18 crore as on 31 December 2016 and Rs 14701.78 crore as on 31 March 2016.

The ratio of gross NPAs to gross advances stood at 13.73% as on 31 March 2017 as against 13.8% as on 31 December 2016 and 9.57% as on 31 March 2016.

The ratio of net NPAs to net advances stood at 8.96% as on 31 March 2017 as against 9.68% as on 31 December 2016 and 6.7% as on 31 March 2016.

Provision coverage ratio of the bank was at 53.61% as on 31 March 2017.

Oriental Bank of Commerces board of directors approved the banks capital plan for raising of capital through FPO / rights issue / private placement / QIP or any other mode approved by Government of India / RBI for an amount not exceeding Rs 25000 crore (including share premium) within the ceiling of authorised capital of the bank at an appropriate time.

Government of India holds 58.37% stake in OBC (as on 31 March 2017).

Powered by Capital Market - Live News

IL&FS Engineering rises after getting LoIs worth Rs 559 crore
May 12,2017

The announcement was made during trading hours today, 12 May 2017.

Meanwhile, the S&P BSE Sensex was down 55.04 points, or 0.18% to 30,195.94.

On the BSE, 93,000 shares were traded in the counter so far, compared with average daily volumes of 32,166 shares in the past one quarter. The stock had hit a high of Rs 57 and a low of Rs 54.30 so far during the day. The stock hit a 52-week high of Rs 66 on 9 September 2016. The stock hit a 52-week low of Rs 36.80 on 22 November 2016.

The stock had underperformed the market over the past one month till 11 May 2017, falling 2.66% compared with 2.05% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 6% as against Sensexs 6.76% rise.

The small-cap company has equity capital of Rs 131.12 crore. Face value per share is Rs 10.

IL&FS Engineering and Construction Company (IL&FS Engineering Services) received Letter of Intents (LoIs) from Jharkhand Bijli Vitran Nigam (JBVNL), Ranchi for rural electrification works of East Singhbhum package comprising East Singhbhum district, and West Singhbum package comprising West Singhbhum districts in Jharkhand under Deen Dayal Upadhyay Gram Jyoti Yojna (DDUGJY).

IL&FS Engineering Services also received LoIs for urban electrification works of Jamshedpur Electric Supply Area of JBVNL covering eight towns (Jamshedpur, Mango, Jugsalai, Chakuliya, Adityapur, Chaibasa, Chakradharpur, and Seraikela) in East Singhbhum, West Singhbum, and Seraikela-Kharsawan districts in Jharkhand under Integrated Power Development Scheme (IPDS) on behalf of JBVNL.

The total value of these contracts is Rs 559.35 crore. The completion schedule of the works is 24 months.

IL&FS Engineering & Construction Company reported net profit of Rs 1.64 crore in Q3 December 2016 as against net loss of Rs 78.57 crore in Q3 December 2015. Net sales declined 9.20% to Rs 397.16 crore in Q3 December 2016 over Q3 December 2015.

IL&FS Engineering and Construction Company is one of the leading infrastructure development, construction and project management companies in India.

Powered by Capital Market - Live News

Orient Bell rings loudly after bulk deal
May 12,2017

Meanwhile, the S&P BSE Sensex was down 115.23 points or 0.38% at 30,135.75. The S&P BSE Small-Cap index was down 147.39 points or 0.94% at 15,506.01.

Bulk deal boosted volume on the scrip. On BSE, so far 15.93 lakh shares were traded in the counter as against average daily volume of 10,034 shares in the past one quarter. The stock hit a high of Rs 275 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 210 so far during the day. The stock had hit a 52-week low of Rs 138.80 on 21 November 2016.

The stock had outperformed the market over the past one month till 11 May 2017, rising 16.08% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, surging 41.48% as against Sensexs 6.76% rise.

The small-cap company has equity capital of Rs 14.19 crore. Face value per share is Rs 10.

Orient Bells net profit rose 59.76% to Rs 2.62 crore on 15.84% decline in net sales to Rs 145.87 crore in Q3 December 2016 over Q3 December 2015.

Orient Bell is engaged in manufacture of ceramic and vitrified tiles.

Powered by Capital Market - Live News

L&T gains after order win
May 12,2017

The announcement was made during trading hours today, 12 May 2017.

Meanwhile, the S&P BSE Sensex was down 89.10 points, or 0.29% to 30,161.88.

On the BSE, 1.16 lakh shares were traded in the counter so far, compared with average daily volumes of 1.55 lakh shares in the past one quarter. The stock had hit a high of Rs 1,757.25 and a low of Rs 1,727.55 so far during the day. The stock hit a 52-week high of Rs 1,771 on 27 April 2017. The stock hit a 52-week low of Rs 1,224 on 24 May 2016.

The stock had outperformed the market over the past one month till 11 May 2017, rising 2.18% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 15.67% as against Sensexs 6.76% rise.

The large-cap company has equity capital of Rs 186.65 crore. Face value per share is Rs 2.

Larsen & Toubro (L&T) has entered into a contract with the Ministry of Defence (MoD) for supply of 100 units of 155mm/ 52 calibre tracked self-propelled gun systems to the Indian Army. The contract is valued at about Rs 4500 crore.

L&T, supported by its South Korean technology partner Hanwha Tech Win (HTW), had bid for this Buy Global acquisition program of MoD in 2011. Among four bidders to the program RFP, L&T emerged as the sole qualified bidder, after a series of user trials and evaluations, based on the performance of the K9 VAJRA-T self-propelled Howitzer.

The K9 VAJRA-T gun is an enhanced version of HTWs K9 Thunder - a world class self- propelled Howitzer, customised and co-developed by LCT HTW to suit the specific requirements of the Indian Army including desert operations. HTWs K9 Thunder self-propelled Howitzer is among the best in the world with over 1,000 units already in service in Korea and few other countries.

This contract embodies the Governments Make in India initiative. It envisages delivery of the 100 guns in 42 months with associated engineering support package and maintenance transfer of technology to support these Howitzer regiments throughout their life cycle. These guns will have over 50% indigenous content and will be delivered from LETs manufacturing facilities, including a new Armoured Systems Complex at Hazira.

This program sets new benchmarks in co-development and co-production of defence systems by any Indian defence company in collaboration with an international technology partner.

L&Ts consolidated net profit rose 38.9% to Rs 972.47 crore on 1.7% growth in net sales to Rs 26018.15 crore in Q3 December 2016 over Q3 December 2015.

L&T is an Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. L&T is Indias largest private sector defence and aerospace company with experience of over three decades in the segment. Hanwha Group, Hanwha Techwins parent company, is the largest private sector defence conglomerate in South Korea.

Powered by Capital Market - Live News

VIP Clothing gallops after turnaround in Q4
May 12,2017

The result was announced after market hours yesterday, 11 May 2017.

Meanwhile, the S&P BSE Sensex was down 71.43 points, or 0.24% to 30,179.55. The S&P BSE Small-Cap index was down 107.27 points, or 0.69% to 15,546.13.

On BSE, so far 13.62 lakh shares were traded in the counter as against an average daily volume of 30,556 shares in the past one quarter. The stock hit a high of Rs 64 and a low of Rs 57.50 so far during the day. The stock had hit a 52-week low of Rs 42.25 on 22 November 2016. The stock had hit a 52-week high of Rs 74.25 on 2 August 2016.

The stock had underperformed the market over the past one month till 11 May 2017, falling 2.08% compared with 2.05% rise in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 2.79% as against Sensexs 6.76% rise.

The small-cap company has an equity capital of Rs 13.22 crore. Face value per share is Rs 2.

VIP Clothings total income rose 53.55% to Rs 59.44 crore in Q4 March 2017 over Q4 March 2016.

VIP Clothing (formerly Maxwell Industries) is engaged in manufacturing and marketing of innerwear. The companys brands include VIP Innerwear, Frenchie, Frenchie X, and VIP Feelings and all of their sub brands.

Powered by Capital Market - Live News

KEC International drops on profit booking
May 12,2017

Meanwhile, the S&P BSE Sensex was down 89.44 points, or 0.3% at 30,161.54. The S&P BSE Mid-cap index was down 116.23 points, 0.78% at 14,840.90.

On the BSE, 50,000 shares were traded on the counter so far as against the average daily volumes of 1.21 lakh shares in the past one quarter. The stock had hit a high of Rs 239 and a low of Rs 231.55 so far during the day.

The stock had hit a record high of Rs 253.10 on 11 May 2017 and a 52-week low of Rs 111.20 on 9 November 2016. The stock had outperformed the market over the past one month till 11 May 2017, advancing 11.15% compared with the Sensexs 1.55% rise. The scrip had also outperformed the market over the past one quarter advancing 44.81% as against the Sensexs 6.76% rise.

The mid-cap company has equity capital of Rs 51.42 crore. Face value per share is Rs 2.

KEC International had rallied 12.12% in the preceding four trading sessions to settle at Rs 237.20 yesterday, 11 May 2017, from its closing of Rs 211.55 on 5 May 2017.

KEC Internationals consolidated net profit spurted 139% to Rs 62.60 crore on 7.5% decrease in net sales to Rs 1882.44 crore in Q3 December 2016 over Q3 December 2015.

KEC International is a global infrastructure engineering, procurement and construction (EPC) major. It has presence in the verticals of power transmission and distribution, cables, railways, renewables and civil.

Powered by Capital Market - Live News

Dr Reddys Lab gains after Q4 results
May 12,2017

The result was announced during trading hours today, 12 May 2017.

Meanwhile, the S&P BSE Sensex was down 93.04 points, or 0.31% to 30,157.94.

On the BSE, 1.25 lakh shares were traded in the counter so far, compared with average daily volumes of 43,185 shares in the past one quarter. The stock had hit a high of Rs 2,615 so far during the day. The stock had hit a low of Rs 2,525.25 so far during the day, which is also a 52-week low for the counter. The stock hit a 52-week high of Rs 3,689 on 20 July 2016.

The stock had underperformed the market over the past one month till 11 May 2017, falling 1.91% compared with 2.05% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.87% as against Sensexs 6.76% rise.

The large-cap drug major has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories co-chairman and CEO, G V Prasad said that FY 2017 had been a challenging year due to lack of new product approvals for the US market. However, the companys other geographies delivered good performances, with several new product launches. The company is also seeing expanded global access to its biosimilars, as a result of successful registrations in emerging markets. The company will continue its focus on rationalisation of cost structures and building a sustainable quality culture across the organisation.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Volumes jump at Orient Bell counter
May 12,2017

Orient Bell clocked volume of 14.94 lakh shares by 12:59 IST on BSE, a 187.03-times surge over two-week average daily volume of 8,000 shares. The stock surged 15.99% to Rs 265.85.

Phoenix Mills notched up volume of 1.28 lakh shares, a 31.57-fold surge over two-week average daily volume of 4,000 shares. The stock rose 1.49% to Rs 418.

Glenmark Pharmaceuticals saw volume of 9.05 lakh shares, a 22.93-fold surge over two-week average daily volume of 39,000 shares. The stock tumbled 14.1% to Rs 776.85. Glenmark Pharmaceuticals reported Q4 March 2017 results after trading hours yesterday, 11 May 2017, which missed market expectations.

On a consolidated basis, Glenmark Pharmaceuticals net profit rose 23.49% to Rs 183.76 crore on 10.23% rise in net sales to Rs 2424.41 crore in Q4 March 2017 over Q4 March 2016. Consolidated earnings before interest, taxation, depreciation and amortization (EBITDA) grew by 46.26% at Rs 443.84 crore in Q4 March 2017 over Q4 March 2016.

Shalimar Paints clocked volume of 4.44 lakh shares, a 8.05-fold surge over two-week average daily volume of 55,000 shares. The stock jumped 12.56% to Rs 267.

Asian Paints saw volume of 7.24 lakh shares, a 7.83-fold rise over two-week average daily volume of 92,000 shares. The stock lost 2.81% to Rs 1,135.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals biggest loser on BSEs A group
May 12,2017

Glenmark Pharmaceuticals slipped 13.98% at Rs 777.90. The stock topped the losers in A group. On the BSE, 8.70 lakh shares were traded on the counter so far as against the average daily volumes of 39,000 shares in the past two weeks.

Jain Irrigation Systems declined 3.56% at Rs 100.10. The stock was the second biggest loser in A group. On the BSE, 5.88 lakh shares were traded on the counter so far as against the average daily volumes of 6.53 lakh shares in the past two weeks.

Zee Entertainment Enterprises fell 3.55% at Rs 526. The stock was the third biggest loser in A group. On the BSE, 1.42 lakh shares were traded on the counter so far as against the average daily volumes of 1.30 lakh shares in the past two weeks.

Yes Bank skid 3.75% at Rs 1,520. The stock was the fourth biggest loser in A group. On the BSE, 2.40 lakh shares were traded on the counter so far as against the average daily volumes of 1.23 lakh shares in the past two weeks.

Alembic Pharmaceuticals tumbled 2.99% at Rs 591. The stock was the fifth biggest loser in A group. On the BSE, 1,584 shares were traded on the counter so far as against the average daily volumes of 18,000 shares in the past two weeks.

Powered by Capital Market - Live News

Zee Entertainment corrects on profit booking
May 12,2017

Meanwhile, the S&P BSE Sensex was down 67.99 points, or 0.22% to 30,182.99.

On the BSE, 1.31 lakh shares were traded in the counter so far, compared with average daily volumes of 91,107 shares in the past one quarter. The stock had hit a high of Rs 545 and a low of Rs 528.70 so far during the day. The stock hit a 52-week high of Rs 588.80 on 3 October 2016. The stock hit a 52-week low of Rs 428.50 on 23 December 2016.

The stock had outperformed the market over the past one month till 11 May 2017, rising 2.79% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 5.21% as against Sensexs 6.76% rise.

The large-cap company has equity capital of Rs 96.04 crore. Face value per share is Re 1.

Shares of Zee Entertainment Enterprises rose 9.88% in two trading sessions to settle at Rs 545.35 yesterday, 11 May 2017, from its close of Rs 496.30 on 9 May 2017.

The recent rally was triggered by the companys strong Q4 March 2017 results. On a consolidated basis, net profit of Zee Entertainment Enterprises rose 568.47% to Rs 1514.22 crore on 0.40% rise in net sales to Rs 1527.95 crore in Q4 March 2017 over Q4 March 2016.

Net profit was boosted by an exceptional income of Rs 1223.44 crore on account of sale of Sports Broadcasting Business to Sony Pictures Network.

Earnings before interest, tax, depreciation and amortization (EBITDA) rose 14% to Rs 468.70 crore in Q4 March 2017 over Q4 March 2016. EBITDA margin stood at 30.7%.

Zee Entertainment Enterprises is one of Indias leading television media and entertainment companies. The company and its affiliate companies have leading presence across the media value chain including television broadcasting, cable distribution, direct-to-home satellite services, digital media and print media amongst others.

Powered by Capital Market - Live News

Glenmark Pharma tumbles as Q4 result miss market expectations
May 12,2017

Meanwhile, the BSE Sensex was down 63.66 points, or 0.21%, to 30,187.32

On the BSE, so far 7.93 lakh shares were traded in the counter, compared with average daily volumes of 31,483 shares in the past one quarter. The stock had hit a high of Rs 835 and a low of Rs 760 so far during the day. The stock hit a 52-week high of Rs 993 on 1 November 2016. The stock hit a 52-week low of Rs 729.30 on 24 June 2016.

On a consolidated basis, Glenmark Pharmaceuticals net profit rose 23.49% to Rs 183.76 crore on 10.23% rise in net sales to Rs 2424.41 crore in Q4 March 2017 over Q4 March 2016. Consolidated earnings before interest, taxation, depreciation and amortization (EBITDA) grew by 46.26% at Rs 443.84 crore in Q4 March 2017 over Q4 March 2016.

Glenmarks consolidated revenue rose 20.08% Rs 9185.68 crore in the year ended 31 March 2017 (FY 2017) over FY 2016. The consolidated EBITDA grew by 41.72% at Rs 20,36.70 crore in FY 2017 over FY 2016.

Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals said that the companys Q4 March 2017 performance was mainly driven by US formulations business. In addition, India business also managed to record growth despite various challenging factors in the market.

Glenmark Pharmaceuticals is a research-driven, global, integrated pharmaceutical organization headquartered at Mumbai, India. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has a diverse pipeline with several compounds in various stages of clinical development primarily focused in the areas of oncology, respiratory disease, and dermatology.

Powered by Capital Market - Live News

Pennar Engineered Building Systems drops after weak Q4 earnings
May 12,2017

The result was announced after market hours yesterday, 11 May 2017.

Meanwhile, the S&P BSE Sensex was down 62.55 points, or 0.21% at 30,188.43. The S&P BSE Small-cap index was down 68.75 points, 0.44% at 15,584.65.

On the BSE, 6,521 shares were traded on the counter so far as against the average daily volumes of 5,311 shares in the past one quarter. The stock had hit a high of Rs 145 and a low of Rs 132.85 so far during the day.

The stock had hit a record high of Rs 204 on 6 September 2016 and a record low of Rs 105 on 14 March 2017. The stock had outperformed the market over the past one month till 11 May 2017, advancing 8.68% compared with the Sensexs 1.55% rise. The scrip had also outperformed the market over the past one quarter advancing 11.27% as against the Sensexs 6.76% rise.

The small-cap company has equity capital of Rs 34.27 crore. Face value per share is Rs 10.

Pennar Engineered Building Systems is one of the leading custom designed building systems solutions providers in India. Its products and services include pre-engineered buildings, design and engineering services, solar module mounting structures, cold form buildings and structural steel products.

Powered by Capital Market - Live News

Force Motors decelerates after weak Q4 result
May 12,2017

The result was announced after market hours yesterday, 11 May 2017.

Meanwhile, the S&P BSE Sensex was down 35.78 points or 0.12% at 30,215.20. The S&P BSE Mid-Cap index was down 59.90 points, or 0.4%, to 14,897.23.

On the BSE, 43,000 shares were traded on the counter so far as against the average daily volumes of 62,883 shares in the past one quarter. The stock had hit a high of Rs 4,600 and a low of Rs 4,475.25 so far during the day.

The stock had hit a record high of Rs 4,839 on 27 October 2016 and a 52-week low of Rs 2,801 on 24 June 2016.

The stock had underperformed the market over the past one month till 11 May 2017, falling 0.11% compared with 2.05% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 9.63% as against Sensexs 6.76% rise.

The mid-cap company has equity capital of Rs 13.18 crore. Face value per share is Rs 10.

Force Motors is a fully, vertically integrated automobile company, with expertise in design, development and manufacture of the full spectrum of automotive components, aggregates and vehicles.

Powered by Capital Market - Live News

TVS Motor gains after tie-up with Guatemalan firm
May 12,2017

The announcement was made after market hours yesterday, 11 May 2017.

Meanwhile, the S&P BSE Sensex was down 31.10 points, or 0.10% to 30,219.88.

On the BSE, 20,000 shares were traded in the counter so far, compared with average daily volumes of 99,738 shares in the past one quarter. The stock had hit a high of Rs 505.50 and a low of Rs 498.75 so far during the day. The stock hit a record high of Rs 518.95 on 27 April 2017. The stock hit a 52-week low of Rs 280.30 on 24 June 2016.

The stock had outperformed the market over the past one month till 11 May 2017, rising 5.22% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 21.44% as against Sensexs 6.76% rise.

The large-cap company has equity capital of Rs 47.51 crore. Face value per share is Re 1.

TVS Motor Company announced its alliance with MASESA (Mayor Servicios Socieda Anonima), a Guatemala-based company that is a leader in the commercialization of motorcycles and Tuk Tuks in the Central American region.

This alliance is in line with the companys plan to expand and strengthen its presence in Central Amn++rica, LATAM, South East Asia and Middle East. In this alliance, MASESA will develop exclusive TVS Motor Company concessionaires in Guatemala, El Salvador, Honduras, Nicaragua and Costa Rica.

MASESA currently operates through a network of 500 touch points throughout the region, which are managed by an extraordinary team, who will manage a wide catalog of parts and service centers duly equipped, guaranteeing the adequate support of the brand and making this alliance one of the most important ones of the industry in recent years in the region.

In the first phase of this association, 5 emblematic exhibition and sales rooms will be installed in the region, which will also offer the entire range of spare parts and technical service, in turn the products of TVS Motor Company will be available in the 500 dealers Masesa has throughout Central America.

Net profit of TVS Motor Company declined 6.8% to Rs 126.77 crore on 1.7% rise in net sales to Rs 2844.50 crore in Q4 March 2017 over Q4 March 2016.

TVS Motor Company is a leading two and three-wheeler manufacturer, and is the flagship company of the TVS Group.

Powered by Capital Market - Live News

Igarashi Motors in reverse gear after poor Q4 result
May 12,2017

The result was announced after market hours yesterday, 11 May 2017.

Meanwhile, the S&P BSE Sensex was down 40.68 points or 0.13% at 30,210.30. The S&P BSE Mid-Cap index was down 87.56 points, or 0.59%, to 14,869.57.

On BSE, so far 1,587 shares were traded in the counter as against average daily volume of 3,725 shares in the past one quarter. The stock hit a high of Rs 891 and a low of Rs 863 so far during the day. The stock had hit a 52-week low of Rs 588.25 on 24 May 2016. The stock had hit a record high of Rs 948 on 4 May 2017.

The stock had outperformed the market over the past one month till 11 May 2017, rising 12.87% compared with 2.05% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 17.46% as against Sensexs 6.76% rise.

The small-cap company has equity capital of Rs 30.61 crore. Face value per share is Rs 10.

Igarashi Motors India manufactures automobile parts. The company specializes in the design and manufacture of small, permanent magnet DC motors and gear motors.

Powered by Capital Market - Live News